Evogene Ltd
NASDAQ:EVGN
Evogene Ltd
NASDAQ:EVGN
Price:
1.04
USD
1.96%
Market Closed
Market Cap:
$9.1m
Balance Sheet
Balance Sheet Decomposition
Evogene Ltd
Evogene Ltd
Balance Sheet Decomposition is not available for
Evogene Ltd
Evogene Ltd
Balance Sheet
Evogene Ltd
Evogene Ltd
Currency: USD
| Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
9
|
15
|
26
|
10
|
6
|
24
|
95
|
5
|
10
|
3
|
3
|
6
|
35
|
46
|
32
|
29
|
21
|
15
|
|
| Cash |
0
|
0
|
0
|
1
|
5
|
6
|
13
|
4
|
3
|
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
9
|
15
|
26
|
9
|
1
|
18
|
83
|
1
|
7
|
1
|
0
|
6
|
35
|
46
|
32
|
29
|
21
|
15
|
|
| Short-Term Investments |
1
|
15
|
12
|
26
|
52
|
31
|
32
|
110
|
90
|
85
|
68
|
49
|
12
|
2
|
22
|
6
|
10
|
0
|
|
| Total Receivables |
0
|
2
|
1
|
3
|
2
|
2
|
2
|
2
|
4
|
1
|
1
|
1
|
2
|
4
|
3
|
2
|
3
|
3
|
|
| Accounts Receivables |
0
|
2
|
1
|
2
|
1
|
2
|
2
|
1
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
2
|
3
|
2
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
2
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Total Current Assets |
10
|
32
|
39
|
39
|
61
|
57
|
130
|
118
|
104
|
90
|
73
|
56
|
49
|
52
|
57
|
38
|
34
|
22
|
|
| PP&E Net |
1
|
1
|
3
|
4
|
7
|
7
|
7
|
9
|
8
|
7
|
5
|
3
|
5
|
4
|
4
|
4
|
3
|
4
|
|
| PP&E Gross |
1
|
1
|
3
|
4
|
7
|
7
|
7
|
9
|
8
|
7
|
5
|
3
|
0
|
0
|
4
|
4
|
3
|
4
|
|
| Accumulated Depreciation |
1
|
1
|
2
|
3
|
4
|
6
|
8
|
10
|
12
|
15
|
17
|
19
|
0
|
0
|
20
|
21
|
23
|
21
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
17
|
16
|
15
|
14
|
13
|
12
|
|
| Long-Term Investments |
0
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Total Assets |
11
N/A
|
34
+223%
|
43
+25%
|
43
N/A
|
68
+58%
|
65
-4%
|
137
+112%
|
128
-7%
|
113
-12%
|
96
-15%
|
78
-19%
|
59
-24%
|
71
+22%
|
72
+1%
|
76
+6%
|
56
-26%
|
51
-9%
|
40
-22%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
1
|
1
|
2
|
3
|
4
|
5
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
2
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
3
|
3
|
2
|
3
|
3
|
2
|
3
|
3
|
2
|
3
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
11
|
|
| Other Current Liabilities |
0
|
2
|
4
|
13
|
5
|
5
|
3
|
3
|
1
|
2
|
1
|
2
|
2
|
6
|
2
|
2
|
2
|
5
|
|
| Total Current Liabilities |
1
|
3
|
6
|
16
|
9
|
10
|
9
|
8
|
6
|
5
|
5
|
5
|
6
|
10
|
7
|
6
|
7
|
19
|
|
| Long-Term Debt |
4
|
6
|
8
|
4
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
11
|
11
|
2
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
11
|
10
|
7
|
17
|
16
|
|
| Other Liabilities |
1
|
16
|
10
|
6
|
8
|
7
|
4
|
4
|
3
|
4
|
4
|
3
|
3
|
4
|
4
|
5
|
5
|
4
|
|
| Total Liabilities |
5
N/A
|
25
+390%
|
24
-4%
|
26
+11%
|
20
-24%
|
17
-16%
|
13
-24%
|
12
-9%
|
9
-23%
|
9
-1%
|
8
-6%
|
9
+5%
|
21
+147%
|
26
+22%
|
23
-12%
|
28
+24%
|
39
+38%
|
41
+6%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
16
|
24
|
28
|
33
|
33
|
36
|
45
|
59
|
77
|
96
|
117
|
138
|
156
|
179
|
207
|
234
|
258
|
274
|
|
| Additional Paid In Capital |
21
|
33
|
47
|
49
|
81
|
84
|
170
|
176
|
180
|
183
|
186
|
188
|
206
|
225
|
261
|
261
|
269
|
272
|
|
| Other Equity |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
6
N/A
|
10
+70%
|
19
+99%
|
17
-13%
|
48
+188%
|
48
+0%
|
125
+158%
|
116
-7%
|
104
-11%
|
87
-16%
|
69
-21%
|
50
-28%
|
50
N/A
|
46
-8%
|
54
+17%
|
28
-48%
|
12
-57%
|
1
N/A
|
|
| Total Liabilities & Equity |
11
N/A
|
34
+223%
|
43
+25%
|
43
N/A
|
68
+58%
|
65
-4%
|
137
+112%
|
128
-7%
|
113
-12%
|
96
-15%
|
78
-19%
|
59
-24%
|
71
+22%
|
72
+1%
|
76
+6%
|
56
-26%
|
51
-9%
|
40
-22%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
10
|
12
|
15
|
15
|
18
|
19
|
25
|
25
|
25
|
26
|
26
|
26
|
26
|
36
|
41
|
41
|
5
|
7
|
|
Switch to:
Switch to:
See Also
Discover More
